A detailed history of Creative Financial Designs Inc transactions in Novavax Inc stock. As of the latest transaction made, Creative Financial Designs Inc holds 12 shares of NVAX stock, worth $99. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12
Previous 12 -0.0%
Holding current value
$99
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 26, 2022

BUY
$134.56 - $217.97 $538 - $871
4 Added 50.0%
12 $2,000
Q3 2021

Oct 08, 2021

SELL
$177.8 - $270.58 $3,556 - $5,411
-20 Reduced 71.43%
8 $2,000
Q2 2021

Jul 27, 2021

BUY
$121.0 - $257.67 $2,420 - $5,153
20 Added 250.0%
28 $6,000
Q1 2021

Apr 19, 2021

BUY
$112.98 - $319.93 $225 - $639
2 Added 33.33%
8 $1,000
Q3 2020

Oct 06, 2020

SELL
$79.44 - $178.51 $11,916 - $26,776
-150 Reduced 96.15%
6 $1,000
Q2 2020

Jul 23, 2020

BUY
$13.86 - $83.61 $2,162 - $13,043
156 New
156 $13,000

Others Institutions Holding NVAX

About NOVAVAX INC


  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $648M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Creative Financial Designs Inc Portfolio

Follow Creative Financial Designs Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Financial Designs Inc , based on Form 13F filings with the SEC.

News

Stay updated on Creative Financial Designs Inc with notifications on news.